MTD Mettler-Toledo International Inc.
MTD Mettler-Toledo International Inc.
Healthcare · Diagnostics & Research
Market read
POC $1,408 · VWAP $1,334 · +21.6% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CFO, Director + 1 other sold $4.8M, Aug 5–7
Coverage
1 watchlist
MTD Price Structure
Loading timeframes…
Peers
Every watchlist MTD belongs to, members best 30-day change first — MTD highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Reported the quarter ending 2026-06-30: revenue $1.03B, diluted EPS $11.55, net income $233M (SEC filing). Across the print the stock moved +2.0% (close before → first close after).
full note →Against street estimates
How MTD's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
MTD research tape
1 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.